Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study

Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study

Dengfeng Ren,1– 3 Guoxiu Wang,4 Yu Zhang,5 Jie Kan,6 Qiuxia Dong,7 Junhui Zhao,3 Faxiang Ji,3 Hao Li,3 Yushuang Luo,3 Mingzhe Lin,3 Guoyuan Li,3 Zhibo Liu,3 Xinfu Ma,8 Qijing Guo,3 Fuxing Zhao,1,2 Guoshuang Shen,2,8 Jiuda Zhao1– 3 1Research Center for High Altitude Medicine, Qing...

Full description

Bibliographic Details
Main Authors: Ren D, Wang G, Zhang Y, Kan J, Dong Q, Zhao J, Ji F, Li H, Luo Y, Lin M, Li G, Liu Z, Ma X, Guo Q, Zhao F, Shen G
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:OncoTargets and Therapy
Subjects:
apatinib
efficacy
safety
elderly patients
advanced gastric cancer
Online Access:https://www.dovepress.com/efficacy-and-safety-of-apatinib-for-elderly-patients-with-advanced-or--peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/efficacy-and-safety-of-apatinib-for-elderly-patients-with-advanced-or--peer-reviewed-fulltext-article-OTT

Similar Items